Intravascular stent
Through the vascular stent woven with ni-titanium alloy wire and polymer polylactic acid material, the influence of mesh structure on branched blood vessels and the risk of plaque shedding in the prior art is solved, and more stable blood flow smoothness and reduced blockage are achieved. Effect.
Patent Information
- Application Number
- CN202411332798.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-24
- Publication Date
- 2024-12-06
AI Technical Summary
When existing vascular stents are implanted into the carotid artery, due to the dense mesh structure, it is easy to affect the blood flow of branched blood vessels, increasing the risk of thrombosis, and reducing the risk of plaque falling off in the mesh density, making it difficult to take into account both.
A mesh structure bracket is woven with a mixture of nickel-titanium alloy wire and degradable polymer polylactic acid material. The thin filaments and thick filaments are arranged at equal spacing ratios of 1:4. The thick filaments form a large mesh structure, and the thin filaments divide the large mesh. Form small grids to increase support while thin filaments can degrade to reduce the impact on the human body.
This stent not only reduces the risk of plaque falling off, but also avoids the impact on branched blood vessels, improves blood flow smoothness, reduces the chance of blood vessel blockage, and filament degradation reduces adverse effects on the human body.
Smart Images

Figure CN119074334A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a blood vessel stent, in particular to an intravascular stent. Background Art
[0002] Hyperlipidemia can cause atheromatous plaques to form on the inner wall of blood vessels. Long-term accumulation leads to thickening of the inner wall of blood vessels, which reduces the diameter of blood vessels and causes local stenosis of blood vessels. The narrowed blood vessels affect the blood supply to distal tissues, causing tissue damage and other phenomena. The incidence rate is high, such as carotid artery stenosis, and the incidence rate in people over 60 years old is as high as 9%.
[0003] The treatments for arterial stenosis mainly include general treatment, drug therapy and interventional methods such as intimal dissection and balloon dilatation. At present, new stent implantation technology has been developed, which uses minimally invasive surgery to implant stents to expand and support the narrowed blood vessel segment, so as to expand the narrowed blood vessel segment, expand its cross-sectional area, and increase blood flow in the blood vessel.
[0004] Vascular stents are medical devices that are placed in the diseased segment based on the formation of luminal balloon dilatation. They are designed to support the narrowed and occluded segment of the blood vessel, reduce the elastic retraction and reshaping of the blood vessel, and thus maintain smooth blood flow in the lumen. Some stents also have the function of preventing restenosis. Most of the current vascular stents are made of elastic metal materials. They are formed into a tubular stent structure by weaving metal wires or laser engraving and hollowing out metal tubes. After being placed in a narrow position, they can support the diameter of the blood vessel. The stent has a mesh structure of a certain density. After the stent is implanted, the mesh structure can prevent the plaque on the blood vessel wall from falling off, thereby causing embolism of the distal blood vessels.
[0005] The mesh of the existing carotid artery braided bare stent is relatively dense, and the carotid artery has many branches. When atheromatous plaques or calcified plaques are located at the branch position or there are plaques at both ends of the branch, the dense mesh structure of the stent will affect the blood flow of the branch after implantation, and it is easy to produce thrombus. The existing technology can solve this problem by reducing the density of braiding, increasing the size of the braided mesh, and increasing the porosity to reduce the impact on the branch blood vessels. However, after the porosity is increased, the fixation effect on the plaque on the blood vessel wall will be reduced, increasing the risk of plaque falling off the blood vessel wall after the stent is implanted.
[0006] Based on the above technical background and existing technologies, we believe that it is necessary to innovate to solve the above problems. Summary of the invention
[0007] The present invention overcomes the deficiencies of the prior art and provides an intravascular stent.
[0008] In order to achieve the above object, the technical solution adopted by the present invention is: an intravascular stent, comprising:
[0009] A stent is used to dilate a blood vessel, wherein the stent is a tubular structure formed by curling a mesh structure;
[0010] The mesh structure is formed by weaving thick filaments and thin filaments together. In the transverse and longitudinal directions of the mesh structure, the thin filaments and the thick filaments are arranged at equal intervals in a certain ratio, and the thin filaments have different elasticity from the thick filaments.
[0011] The stent includes a natural state, a compressed state and an expanded state. The natural state is the initial state before the stent is implanted into a branch vessel; the compressed state is the state when the stent is implanted into a branch vessel; and the expanded state is the state after the stent is expanded.
[0012] In a preferred embodiment of the present invention, the certain ratio is: 1:1-6.
[0013] In a preferred embodiment of the present invention, the thin filaments have less elasticity than the thick filaments.
[0014] In a preferred embodiment of the present invention, the thick wire is made of nickel-titanium alloy wire, and the thin wire is made of degradable material.
[0015] In a preferred embodiment of the present invention, the degradable material is a high molecular weight polylactic acid material.
[0016] In a preferred embodiment of the present invention, in the natural state, the diameter of the stent is larger than the inner diameter of the blood vessel.
[0017] In a preferred embodiment of the present invention, the expansion state includes stent expansion and stent partial expansion.
[0018] In a preferred embodiment of the present invention, the stent expansion is a stent self-expanding expansion, and the stent local expansion includes: a conical catheter passing process or a balloon dilation process.
[0019] In a preferred embodiment of the present invention, an anti-inflammatory coating is applied on the surface of the stent.
[0020] In a preferred embodiment of the present invention, the anti-inflammatory coating is an anti-proliferative agent.
[0021] The present invention solves the defects existing in the background technology and has the following beneficial effects:
[0022] (1) The present invention provides a vascular stent with a braided structure. The stent is made of two materials with different elasticity that are mixed and woven. The material with stronger elasticity provides radial support force to anchor the stent as a whole on the blood vessel wall, and the material with weaker elasticity fits the blood vessel to prevent the embolic plaque from falling off. At the same time, at the opening of the branch blood vessel, due to the characteristics of the mixed braided structure, the mesh structure of the stent can be intervened to open the blood flow of the branch blood vessel after the stent is implanted. Compared with the prior art, the stent structure not only meets the requirements of the dense stent mesh structure to reduce the risk of plaque falling off, but also avoids the influence of the dense mesh structure on the branch blood vessel.
[0023] (2) The stent is made of a mixture of nickel-titanium alloy wire and high molecular weight polylactic acid, with thin filaments and thick filaments arranged at equal intervals in a ratio of 1:4, and the elasticity of the thin filaments is smaller than that of the thick filaments; the thick filaments form a large grid structure, and the thin filaments divide the large grid and form multiple small grids. The large grid structure meets the support performance required for stent anchoring, while the small grid fills the problem of insufficient mesh density of the thick wires; the risk of plaque detachment is further reduced, while avoiding the influence of the dense mesh structure on the branch blood vessels.
[0024] (3) The openings of the branch blood vessels are also opened to reduce the impact of vascular stenosis at the branch blood vessels and reduce the chance of vascular blockage.
[0025] (4) The filaments are made of degradable materials; the thick filaments can normally dilate the blood vessels, and the thin filaments can be degraded in the blood vessels; compared with the existing technology, the filaments are degraded in the blood vessels, reducing the adverse effects on the human body. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For those of ordinary skill in the art, other drawings can be obtained based on these drawings without creative work.
[0027] Figure 1 It is a three-dimensional structural diagram of the side surface of the bracket of the present invention;
[0028] Figure 2 It is a partial detail diagram of the braiding of thick and thin filaments of the present invention;
[0029] Figure 3 It is a detailed view of the local opening of the braided thick and thin filaments of the present invention;
[0030] Figure 4 This is a schematic diagram of the operation of implanting the intravascular stent of the present invention into a blood vessel;
[0031] In the figure: 1, stent; 12, thin filament; 13, thick filament; 15, hole; 2, balloon. DETAILED DESCRIPTION
[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0033] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein. Therefore, the protection scope of the present invention is not limited to the specific embodiments disclosed below.
[0034] In the description of the present application, it should be understood that the terms "center", "longitudinal", "lateral", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", etc., indicating orientations or positional relationships, are based on the orientations or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as limiting the scope of protection of the present application.
[0035] like Figure 1 As shown, an intravascular stent comprises: a stent 1 for dilating a blood vessel, wherein the stent 1 is a tubular structure formed by curling a mesh structure;
[0036] The mesh structure is woven by mixing thick filaments and thin filaments. In the transverse and longitudinal directions of the mesh structure, the thin filaments 12 and the thick filaments 13 are arranged at equal intervals in a certain ratio, and the elasticity of the thin filaments 12 is different from that of the thick filaments 13.
[0037] The stent includes a natural state, a compressed state and an expanded state. The natural state is the initial state before the stent is implanted into a branch vessel; the compressed state is the state when the stent is implanted into a branch vessel; and the expanded state is the state after the stent is expanded.
[0038] like Figure 4 As shown, in the present invention, the expansion state includes the expansion of the stent 1 and the partial expansion of the stent 1;
[0039] The expansion of the stent 1 is to place the stent 1 from a compressed state into the branch blood vessel, and the stent 1 expands by itself. The stent 1 expands by itself under the recovery of its own elasticity, thereby stretching the blood vessel, so that the stent 1 fits the inner wall of the blood vessel better, and the stent 1 is better erected on the inner wall of the blood vessel;
[0040] like Figure 2 As shown, the local expansion of the stent 1 is that the balloon 2 expands at a local position of the stent 1, which can expand the filaments 12 with less elasticity, so that the stent 1 is partially opened, which is convenient for opening at the branching position of the branch blood vessel, and making multiple holes 15, which can reduce the blockage of the stent 1 at the branching position of the blood vessel;
[0041] It should be added that another implementation method of local expansion of the stent 1 may also use a tapered catheter to destroy the filaments 12 to create holes 15, thereby causing the stent to expand locally.
[0042] like Figure 3 As shown, a plurality of thick wires 13 form a large grid structure, which constitutes the main stent of the vascular stent and can be used as the main radial support component of the vascular stent, and a plurality of thin wires 12 divide the large grid structure to form a small grid structure as a secondary stent, which can be used as a secondary radial support for branch blood vessels. The large grid structure and the small grid structure are both pore structures, and the large grid structure is divided into small grid structures by the thin wires 12.
[0043] In the present invention, thick filaments 13 and thin filaments 12 having less elasticity than the thick filaments are mixed and woven.
[0044] In the present invention, the thick wire 13 is made of nickel-titanium alloy wire; the thin wire 12 is made of high molecular weight polylactic acid material. The wire diameter of the thick wire 13 is 0.08mm-0.18mm, the wire diameter of the thin wire 12 is 0.04mm-0.18mm, the elastic modulus of the thick wire is 200GPa, and the elastic modulus of the thin wire is 100GPa. The nickel content of the nickel-titanium alloy wire is 52%, the titanium content is 43%, the copper content is 2.9%, the cobalt content is 0.2%, and the niobium content is 0.9%, and it is prepared by a rapid solidification method;
[0045] Polylactic acid is made by polymerizing L-lactic acid (PLLA). During the degradation process of polylactic acid in the body, its degradation product lactic acid is a small molecule compound widely present in nature, which is non-toxic and harmless to the human body and can be metabolized into water and carbon dioxide by human cells and excreted from the body. Therefore, polylactic acid has good compatibility with human tissues and is not easy to cause inflammation and immune rejection reactions after implantation in the body.
[0046] The mesh structure of the present invention is woven by a braiding machine. Specifically, thick filaments and thin filaments are interwoven. During the braiding process, the ratio of the thin filaments 12 to the thick filaments 13 is controlled to be in the range of 16-144 strands.
[0047] The method of curling and forming the mesh structure in the present invention is: a flat film rolling method;
[0048] The planar film rolling method is to roll a two-dimensional fiber membrane or film into a tubular stent of the required diameter, realizing the transformation of planar materials into three-dimensional materials; the planar film rolling method is easy to operate and can produce multi-layered and microstructured vascular tissue stents. When making vascular tissue stents, you can first design the required layers and morphology of the stent, and then use the planar material production technology to first produce the corresponding material components on the plane, and finally stack and roll the materials to form a vascular tissue stent with multiple layers and morphologies.
[0049] The mesh structure is curled and formed into a tubular structure, namely a vascular stent in a natural state, and its diameter is 4mm-24mm.
[0050] The thin wire 12 and the thick wire 13 have different elasticity, specifically: the stent is composed of nickel-titanium alloy wire; the thin wire 12 and the thick wire 13 have different elasticity, and the stent is composed of nickel-titanium alloy wire + high molecular weight polylactic acid;
[0051] The thin wires 12 and the thick wires 13 are arranged at equal intervals according to a certain ratio, specifically, the certain ratio is 1:1-6; more specifically, the certain ratio is 1:1, 1:2, 1:4 or 1:6. Among them, 1:1 means that two thick wire brackets are spaced one thin wire apart, and 1:4 means that two thick wire brackets are spaced four thin wires apart.
[0052] The surface of the stent 1 is provided with an anti-inflammatory coating to reduce inflammation of branch vessels leading to intravascular edema and resulting in the narrowing of the vascular channel. Specifically, the anti-inflammatory coating is an anti-proliferative agent, wherein the anti-proliferative agent is sirolimus, which can effectively inhibit the proliferation of vascular smooth muscle cells and reduce excessive proliferation of the endothelium, thereby reducing the restenosis rate.
[0053] Specifically, the coating thickness of the anti-inflammatory coating is between 9μm-73μm. The anti-inflammatory coating adopts ultrasonic spraying technology to make the drug solution evenly distributed on the product surface through the ultrasonic nozzle, thereby preparing a uniform, non-adhesion, and pinhole-free anti-inflammatory coating.
[0054] In the present invention, the diameter of the stent 1 is naturally larger than the inner diameter of the blood vessel. The thick wire, as a nickel-titanium alloy wire, has a better deformation recovery effect. When the stent 1 is expanded, it can better fit the inner wall of the blood vessel, making it easier to fix the stent 1 faster and more stably.
[0055] Experimental Example 1
[0056] An intravascular stent comprises: a stent 1 for supporting a branch blood vessel, wherein the stent 1 is a tubular structure formed by curling a mesh structure;
[0057] The mesh structure is woven by a mixture of thick filaments and thin filaments. In the transverse and longitudinal directions of the mesh structure, the diameter of the thick filaments 13 is 0.1 mm, the diameter of the thin filaments 12 is 0.06 mm, the diameter of the tubular structure is 6 mm, the coating thickness of the anti-inflammatory coating is 9 μm, and the weaving ratio of the thin filaments 12 to the thick filaments 13 is 50 strands. The diameter of the vascular stent in its natural state is 10 mm, the elastic modulus of the thick filaments is 200 GPa, and the elastic modulus of the thin filaments is 100 GPa.
[0058] In order to demonstrate the effect of mixed weaving of materials with different elasticity and different weaving ratios on the blood flow in branch vessels, samples 1-8 were designed. The difference between samples 1-8 and the intravascular stent prepared in Experimental Example 1 lies in the materials of thick and thin filaments, and the ratio of thin filaments to thick filaments.
[0059] The experimental method includes: using a blood vessel model (artificial blood vessel or animal blood vessel model), implanting the above samples 1-8 in the blood vessel model, and using a conical catheter to pass through or balloon dilation to make the samples 1-8 fit the inner wall of the blood vessel, and performing a blood routine test on the blood in the blood vessel (i.e., the amount of thrombocytopenia and the amount of red blood cells increased); the higher the amount of thrombocytopenia and the amount of red blood cells increased, the more serious the blockage; the results are shown in Table 1;
[0060] Experimental Example 2
[0061] An intravascular stent comprises: a stent 1 for supporting a branch blood vessel, wherein the stent 1 is a tubular structure formed by curling a mesh structure;
[0062] The mesh structure is woven by mixing thick filaments and thin filaments. In the transverse and longitudinal directions of the mesh structure, the diameter of the thick filaments 13 is 0.1 mm, the diameter of the thin filaments 12 is 0.06 mm, the diameter of the tubular structure is 6 mm, the coating thickness of the anti-inflammatory coating is 9 μm, and the weaving ratio of the thin filaments 12 to the thick filaments 13 is 50 strands. The diameter of the vascular stent in the natural state is 10 mm.
[0063] In order to demonstrate the effect of mixed weaving of materials with different elasticity and different weaving ratios on the risk of plaque detachment in branch vessels, samples 1-8 were designed. The difference between samples 1-8 and the intravascular stent prepared in Experimental Example 1 lies in the materials of thick and thin filaments, and the ratio of thin filaments to thick filaments.
[0064] A vascular model (artificial vascular model or animal vascular model) is used, and the above samples 1-8 are implanted in the vascular model, and a conical catheter is used for penetration or balloon dilation to make the samples 1-8 fit the inner wall of the blood vessel. Ultrasonic imaging is used to detect the carotid artery intima-media thickness (IMT) of the plaque inside the blood vessel; the IMT judgment standard is:
[0065] IMT<1.0mm: normal, almost no plaque;
[0066] IMT1.0-1.5mm: Intima-media thickening, plaques gradually formed;
[0067] IMT>1.5mm: more plaque formation;
[0068] The results are shown in Table 1;
[0069]
[0070]
[0071] According to Table 1, the test results of thrombocytopenia, red blood cell increase and IMT test results show that the vascular stent made of nickel-titanium alloy wire has the highest red blood cell increase, and the vascular stent made of nickel-titanium alloy wire + polymer polylactic acid has the lowest red blood cell increase; this shows that the vascular stent composed of nickel-titanium alloy wire + polymer polylactic acid has the lowest effect on thrombocytopenia and red blood cell increase; this means that the vascular stent composed of nickel-titanium alloy wire + polymer polylactic acid with different elasticity is the least likely to cause vascular blockage; the reason is that: the mesh structure woven by the mixed use of nickel-titanium alloy wire and polymer polylactic acid forms a complex interpenetrating network at the microscopic level compared to the use of nickel-titanium alloy wire alone, and the stent composed of nickel-titanium alloy wire with different elasticities and polymer polylactic acid complements each other with different elasticities, which produces a more uniform stress distribution when subjected to external force, reduces the phenomenon of local stress concentration, reduces the impact on vascular blockage and reduces plaque shedding.
[0072] According to Table 1, the test results of thrombocytopenia, red blood cell increase and IMT show that the vascular stent made with a ratio of 1:1 has the highest red blood cell increase, followed by 1:6, then 1:2, and finally 1:4 has the lowest red blood cell increase; this shows that the vascular stent with a ratio of 1:4 is the best for reducing plaque detachment and reducing blood vessel blockage; the reason is that compared with the ratios of 1:1, 1:2 and 1:6, the ratio of 1:4 does not cause much impact on blood vessel circulation while fixing the plaque, and the effect of fixing the plaque and blood vessel flow is the most stable.
[0073] In summary, the experimental data show that the vascular stent composed of a weaving ratio of 1:4 has the least effect on plaque detachment, and the vascular stent composed of nickel-titanium alloy wire + high molecular weight polylactic acid has the least effect on plaque detachment.
[0074] The above is based on the ideal embodiment of the present invention. Through the above description, relevant personnel can make various changes and modifications without departing from the technical concept of the present invention. The technical scope of the present invention is not limited to the content in the specification, and the technical scope must be determined according to the scope of the claims.
Claims
1. An intravascular stent, characterized in that: include: A stent (1) is used for dilating a blood vessel, wherein the stent (1) is a tubular structure formed by curling a mesh structure; The mesh structure is formed by weaving a mixture of thick filaments and thin filaments. In the transverse and longitudinal directions of the mesh structure, the thin filaments (12) and the thick filaments (13) are arranged at equal intervals in a certain ratio. The thin filaments (12) have different elasticity from the thick filaments (13). The stent includes a natural state, a compressed state and an expanded state. The natural state is the initial state before the stent is implanted into a branch vessel; the compressed state is the state when the stent is implanted into a branch vessel; and the expanded state is the state after the stent is expanded.
2. An intravascular stent according to claim 1, characterized in that: The certain ratio is 1:1-6.
3. The intravascular stent according to claim 1, characterized in that: The thin filaments (12) have less elasticity than the thick filaments (13).
4. The intravascular stent according to claim 1, characterized in that: The thick wire (13) is made of nickel-titanium alloy wire, and the thin wire (12) is made of degradable material.
5. The intravascular stent according to claim 4, characterized in that: The degradable material is a high molecular weight polylactic acid material.
6. The intravascular stent according to claim 1, characterized in that: In the natural state, the diameter of the stent (1) is larger than the inner diameter of the blood vessel.
7. The intravascular stent according to claim 1, characterized in that: The expansion state includes expansion of the stent (1) and partial expansion of the stent (1).
8. The intravascular stent according to claim 7, characterized in that: The expansion of the stent (1) is a self-expanding expansion of the stent (1), and the local expansion of the stent (1) includes: a conical catheter passing process or a balloon (2) expansion process.
9. The intravascular stent according to claim 1, characterized in that: The surface of the stent (1) is provided with an anti-inflammatory coating.
10. The intravascular stent according to claim 1, characterized in that: The anti-inflammatory coating is an anti-proliferative agent.
Citation Information
Patent Citations
Vessel stent and production method thereof
CN104720941A
Bare stent capable of being compressed in axial direction
CN113893071A
Medical support
CN115702842A
Medical support
CN117860451A
Medical support
CN118383912A
